← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Orphi Therapeutics, Inc.
Carlsbad, CA
$1,869,380
Total funding
3
Grants
Funding over time
peak $860.2K · FY2015–18$1M$750K$500K$250K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$1,869,380 · 3
By mechanism
R44$1,494,785 · 1
R43$374,595 · 2
Investigators at Orphi Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Pharmacological Chaperone Therapy for the GM2 Gangliosidoses$860,232
R44 · FY2017 · NS
Pharmacological Chaperone Therapy for the GM2 Gangliosidoses$634,553
R44 · FY2018 · NS
Optimization and Lead Selection of an Iminosugar Pharmacological Chaperone for the Treatment of Alzheimer's Disease$224,914
R43 · FY2015 · AG
Pharmacological Chaperone Therapy for the GM2 Gangliosidoses$149,681
R43 · FY2015 · NS